Last update 21 Nov 2024
AS03-adjuvanted cH5/1N1 IIV(PATH)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Prophylactic vaccine |
Synonyms- |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with AS03-adjuvanted cH5/1N1 IIV(PATH)A Phase 1, Randomized, Controlled, Observer-blind Study to Assess the Reactogenicity, Safety, and Immunogenicity of a Live Attenuated Universal Influenza Vaccine (cH8/1N1 LAIV) Administered as a Single Priming Dose Followed Three Months Later by a Single Booster Dose of an Inactivated Universal Influenza Vaccine (cH5/1N1 IIV) (Adjuvanted With AS03A or Unadjuvanted) in 18 Through 39 Year-old Healthy Subjects, Contrasted With a Two Dose Schedule of an Inactivated Universal Influenza Vaccine (cH8/1N1 IIV + AS03A Followed Three Months Later by cH5/1N1 IIV + AS03A)
100 Clinical Results associated with AS03-adjuvanted cH5/1N1 IIV(PATH)
Login to view more data
100 Translational Medicine associated with AS03-adjuvanted cH5/1N1 IIV(PATH)
Login to view more data
100 Patents (Medical) associated with AS03-adjuvanted cH5/1N1 IIV(PATH)
Login to view more data
100 Deals associated with AS03-adjuvanted cH5/1N1 IIV(PATH)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Influenza, Human | Phase 1 | US | 10 Oct 2017 | |
| Influenza, Human | Phase 1 | US | 10 Oct 2017 | |
| Influenza, Human | Phase 1 | US | 10 Oct 2017 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | 65 | (Group 1: cH8/1N1 LAIV and cH5/1N1 IIV + Adjuvant) | kyxoimbsgs(cnbpnokjmf) = edjgjietim dlkbibtqnh (oluqzqpstu, nhvrazdtps - mwsjbeslga) View more | - | 21 Feb 2021 | ||
(Group 2: cH8/1N1 LAIV and cH5/1N1 IIV) | kyxoimbsgs(cnbpnokjmf) = kjkmaywvxh dlkbibtqnh (oluqzqpstu, gbpbejjjao - bzbuqwpgnx) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free